Literature DB >> 21443722

Gene, environment, and brain-gut interactions in irritable bowel syndrome.

Shin Fukudo1, Motoyori Kanazawa.   

Abstract

The genetic predisposition and influence of environment may underlie in the pathogenesis and/or pathophysiology of irritable bowel syndrome (IBS). This phenomenon, gene x environment interaction together with brain-gut interactions is emerging area to be clarified in IBS research. Earlier studies focused on candidate genes of neurotransmitters, cytokines, and growth factors. Among them, some studies but not all studies revealed association between phenotypes of IBS and 5-hydroxytryptamine (5-HT)-related genes, noradrenaline-related genes, and cytokine genes. Recent prospective cohort study showed that genes encoding immune and adhesion molecules were associated with post-infectious etiology of IBS. Psychosocial stressors and intraluminal factors especially microbiota are keys to develop IBS. IBS patients may have abnormal gut microbiota as well as increased organic acids. IBS is disorder that relates to brain-gut interactions, emotional dysregulation, and illness behaviors. Brain imaging with or without combination of visceral stimulation enables us to depict the detailed information of brain-gut interactions. In IBS patients, thalamus, insula, anterior cingulate cortex, amygdala, and brainstem were more activated in response to visceral stimulation than controls. Corticotropin-releasing hormone and 5-HT are the candidate substances which regulate exaggerated brain-gut response. In conclusion, gene x environment interaction together with brain-gut interactions may play crucial roles in IBS development. Further fundamental research on this issue is warranted.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21443722     DOI: 10.1111/j.1440-1746.2011.06631.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  37 in total

1.  IBS: Autonomic dysregulation in IBS.

Authors:  Shin Fukudo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-03       Impact factor: 46.802

Review 2.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 3.  Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Authors:  Yehuda Ringel; Nitsan Maharshak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

4.  Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance.

Authors:  Geng Qin; Yu Zhang; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

5.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 6.  Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

Authors:  Maria M Buckley; Siobhain M O'Mahony; Dervla O'Malley
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain.

Authors:  Jui-Yang Hong; Lisa A Kilpatrick; Jennifer Labus; Arpana Gupta; Zhiguo Jiang; Cody Ashe-McNalley; Jean Stains; Nuwanthi Heendeniya; Bahar Ebrat; Suzanne Smith; Kirsten Tillisch; Bruce Naliboff; Emeran A Mayer
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

8.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

9.  New paradigm for studying genetic contributions to irritable bowel syndrome.

Authors:  Miranda A L van Tilburg; William E Whitehead
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

10.  Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences.

Authors:  Arpana Gupta; Lisa Kilpatrick; Jennifer Labus; Kirsten Tillisch; Adam Braun; Jui-Yang Hong; Cody Ashe-McNalley; Bruce Naliboff; Emeran A Mayer
Journal:  Psychosom Med       Date:  2014 Jul-Aug       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.